시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 의약품 시장 - 규모, 점유율, 성장 분석 : 분자별, 제품별, 유형별, 질환별, 투여법별, 처방별, 연령별, 최종 용도별, 지역별 산업 예측(2024-2031년)
Pharmaceuticals Market Size, Share, Growth Analysis, By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Disease, By Administration, By Formulation, By Age, By End Use, By Region - Industry Forecast 2024-2031
상품코드 : 1619108
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 165 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,657,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,957,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,258,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

의약품 세계 시장 규모는 2022년에 2,098억 5,000만 달러로 평가되었고, 2023년 2,224억 4,000만 달러에서 2031년에는 3,545억 4,000만 달러로 성장해 예측기간(2024-2031년) CAGR은 6.0%로 성장할 전망입니다.

의약품은 의료 목적으로 처방되는 약제 함유 제품으로 정의되며 건강과 웰니스에 대한 소비자의 의식이 높아짐에 따라 수요가 급증하고 있습니다. 백신 개발을 담당하는 제약회사는 경제 불안 속에서 살아남았을 뿐만 아니라 번영해, 이 섹터의 회복력을 부조로 했습니다. 개인이 건강을 우선하게 되어, 의약품 시장은 지속적으로 성장하는 태세가 갖추어져 있습니다. 시장의 지속적인 확대를 보장합니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

의약품 시장 규모 : 분자별 및 CAGR(2024-2031년)

의약품 시장 규모 : 제품별 및 CAGR(2024-2031년)

의약품 시장 규모 : 유형별 및 CAGR(2024-2031년)

의약품 시장 규모 : 질환별 및 CAGR(2024-2031년)

의약품 시장 규모 : 투여법별 및 CAGR(2024-2031년)

의약품 시장 규모 : 처방별 및 CAGR(2024-2031년)

의약품 시장 규모 : 연령별 및 CAGR(2024-2031년)

의약품 시장 규모 : 최종 용도별 및 CAGR(2024-2031년)

의약품 시장 규모 및 CAGR(2024-2031년)

경쟁 정보

주요 기업 프로파일

결론과 권장사항

JHS
영문 목차

영문목차

Global Pharmaceuticals Market size was valued at USD 209.85 billion in 2022 and is poised to grow from USD 222.44 billion in 2023 to USD 354.54 billion by 2031, growing at a CAGR of 6.0% during the forecast period (2024-2031).

Pharmaceuticals, defined as drug-containing products formulated for medical purposes, are witnessing a surge in demand, driven by increasing consumer awareness about health and wellness. This trend accelerated during the COVID-19 pandemic, where pharmaceutical companies responsible for vaccine development not only survived but thrived amidst economic instability, highlighting the sector's resilience. As individuals prioritize their health, the pharmaceutical market is poised for continued growth. The ongoing commitment to healthcare solutions underscores the essential role of pharmaceuticals in society, ensuring sustained market expansion as long as public health needs persist. With a focus on innovation and accessibility, the industry is well-positioned to meet the evolving demands of consumers in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceuticals Market Segmental Analysis

Global Pharmaceuticals Market is segmented by molecule, product, type, disease, administration, formulation, age, end use and region. Based on molecule, the market is segmented into biologics & biosimilars (large molecules) and conventional drugs (small molecules). Based on product, the market is segmented into branded and generic. Based on type, the market is segmented into prescription and OTC. Based on disease, the market is segmented into cardiovascular diseases, cancer, diabetes, infectious diseases, neurological disorders, respiratory diseases, autoimmune diseases, mental health disorders, gastrointestinal disorders, women's health diseases, genetic and rare genetic diseases, dermatological conditions, obesity, renal diseases, liver conditions, hematological disorders, eye conditions, infertility conditions, endocrine disorders, allergies and others. Based on administration, the market is segmented into oral, topical, parenteral, inhalations and other. Based on formulation, the market is segmented into tablets, capsules, injectable, sprays, suspensions, powders and other formulations. Based on age, the market is segmented into children & adolescents, adults and geriatric. Based on end use, the market is segmented into hospitals, clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceuticals Market

One of the key drivers of the Global Pharmaceuticals market is the rising aging population. Recent data from the Bureau of Census highlights a growth in the demographic of individuals aged 65 and older, increasing from 8% in 2015 to 9% in 2021. This demographic shift results from improved living standards and an expanding global population, significantly altering the population structure in many nations. The United Nations projects a staggering 56% rise in individuals aged 60 and above from 2015 to 2030. As people live longer, age-related health issues are becoming more prevalent, putting enormous pressure on healthcare systems worldwide. This scenario creates a critical need for innovative pharmaceutical solutions, as advancements in nanotechnology and artificial intelligence offer promising avenues to develop new treatments. Consequently, the growing patient base directly fuels the demand for medical interventions, driving substantial growth in the pharmaceuticals market.

Restraints in the Global Pharmaceuticals Market

The global pharmaceuticals market faces significant restraints stemming from a shortage of skilled labor and the volatility of raw material costs. The development of new drugs necessitates specialized skill sets that are currently available only in select research organizations, leading to an inadequate workforce. Additionally, fluctuating raw material prices hinder market expansion, creating further challenges for pharmaceutical companies. Compounding these issues is a pronounced talent gap, as the skills possessed by the current workforce do not adequately align with the advanced requirements of biopharma production. Companies struggle to find expertise in critical areas like automation, computer science, and process modeling, hindering innovation and progress within the industry.

Market Trends of the Global Pharmaceuticals Market

The Global Pharmaceuticals market is experiencing a significant trend toward restructuring and recovery post-COVID-19, as companies adapt to the new normal. As the demand for innovative therapies surges, firms are pivoting their business models to enhance resilience against future disruptions. The pandemic catalyzed a shift to digital health solutions and telemedicine, prompting pharmaceutical companies to invest in technology and streamline operations. There is also an increased focus on supply chain diversification and sustainability practices. This evolving landscape presents opportunities for growth and collaboration, positioning the pharmaceutical sector for a robust rebound and long-term evolution in healthcare delivery and access.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Pharmaceuticals Market Size by Molecule & CAGR (2024-2031)

Global Pharmaceuticals Market Size by Product & CAGR (2024-2031)

Global Pharmaceuticals Market Size by Type & CAGR (2024-2031)

Global Pharmaceuticals Market Size by Disease & CAGR (2024-2031)

Global Pharmaceuticals Market Size by Administration & CAGR (2024-2031)

Global Pharmaceuticals Market Size by Formulation & CAGR (2024-2031)

Global Pharmaceuticals Market Size by Age & CAGR (2024-2031)

Global Pharmaceuticals Market Size by End Use & CAGR (2024-2031)

Global Pharmaceuticals Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기